Related Experiment Videos
Imaging molecular signatures in oligodendroglioma
1Department of Clinical Neurosciences, University of Calgary and Tom Baker Cancer Centre, Calgary, Alberta, Canada. jgcairnx@ucalgary.ca
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A Phase 1/2 Study of Disulfiram and Copper With Concurrent Radiation Therapy and Temozolomide for Patients With Newly Diagnosed Glioblastoma.
International journal of radiation oncology, biology, physics·2024
Joint Final Report of EORTC 26951 and RTOG 9402: Phase III Trials With Procarbazine, Lomustine, and Vincristine Chemotherapy for Anaplastic Oligodendroglial Tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2022
A Phase II Trial of Pembrolizumab plus Granulocyte-Macrophage Colony-Stimulating Factor in Advanced Biliary Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
BRIGHTLINE-1: When a Negative Trial Reveals Two Active Therapies.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
EZH2 Inhibition and Myeloid Risk: A Feature of On-Target Biology.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
The pan-tumor landscape, allelic status, and genomic complexity of SMARCA4 alterations.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Clinical, genomic, and spatial transcriptomic features of pancreatic adenosquamous carcinoma support subtype-specific therapeutic strategies.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Phase II trial of First-Line Axitinib Plus Nivolumab in Patients with Advanced Mucosal Melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026